(2021) reported the discovery of a dual PDE1B/10A inhibitor, Compound 84 (Zinc41306568) , with IC 50 values of 0.85 M for PDE1B and 1.34 M for PDE10A
It should be used thoughtfully alongside other healthy lifestyle choices to optimize its potential benefits
Sikiric et al., 2020b) is focused on the particular skin wound therapy, incisional/excisional wound (Seiwerth et al., 1997), deep burns (Mikus et al., 2001), diabetic ulcer (Tkalecevic et al., 2007), alkali burns (Staresinic et al., 2003
ROR = 5.72, 95% CI 5.176.33) These findings not only validate known safety concerns but also highlight potential areas for further pharmacovigilance monitoring and clinical investigation